Clinical Trial

Hearing Loss Clinical Trial 2015-013

[LCID Study Number: 2015-013]

Nucleus Hybrid L24 Implant System: New Enrollment Study

The purpose of this study is to evaluate the safety and effectiveness outcomes obtained from the Nucleus Hybrid L24 cochlear implant system.

Disease/Condition: Hearing Loss

Department: Otolaryngology/Head and Neck Surgery

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact EmailEva.M.Bero@lahey.org

Clinical Trial Details

View NCT ID 02379819 on ClinicalTrials.gov

Protocol #: 2015-013

Principal Investigator(s): Elizabeth H. Toh

Study Coordinator(s): Eva Bero

Trial Phase: Sponsor Initiated Study Category B Device